Cancer Genetics Inc (NASDAQ:CGIX)

1.78
Delayed Data
As of Feb 22
 +0.025 / +1.43%
Today’s Change
1.55
Today|||52-Week Range
5.30
-4.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-12.4M-16.6M-20.2M-15.8M
 
 
 
 
 
Depreciation326.5K838.6K1.7M2.4M
 
 
 
 
 
Total Other Cash Flow5.8M4.6M4.0M1.2M
 
 
 
 
 
Funds From Operations-6.3M-11.2M-14.5M-12.2M
 
 
 
 
 
Funds From/For Other Operating Expenses1.8M1.2M-934.0K5.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.1M-12.3M-13.6M-17.9M
 
 
 
 
 
 
InvestingIncrease In Investments-1.0M-1.0M0.000.00
 
 
 
Decrease In Investments0.000.006.0M0.00
 
 
Capital Expenditures-257.3K-1.4M-1.0M-490.0K
 
 
 
 
 
Fixed Asset Disposal--312.0K-7.5M0.00
 
 
 
Net Assets From Acquisitions 0.00-3.2M0.000.00
 
 
Other Investing - Uses-50.0K-6.0M0.000.00
 
 
 
Net Cash Flow Investing-1.4M-11.4M-2.6M-609.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.00-33.0K0.00
 
 
Long Term Debt Reduction-3.6M-452.2K-83.0K-1.5M
 
 
 
 
 
Net Proceeds Stock Sale61.7M257.1K10.3M10.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing58.1M-195.1K10.1M8.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash48.6M-23.9M-6.1M-10.0M